Search All News
Dystonia, when muscles contract uncontrollably, would be disconcerting to anyone, but it can be a career-ending disorder for trained musicians.
Even in people with complete paralysis after spinal cord injury, some nerves fibers are preserved. A Columbia physician-scientist is developing a new way to salvage those fibers and restore movement.
To treat a young child with an ultrarare neurological disorder, her Columbia doctor has turned to a custom drug designed for a single patient.
- December 15, 2022
The Carol and Gene Ludwig Center for Research on Neurodegeneration will bring novel approaches to Alzheimer’s and other neurodegenerative disease research.
- July 25, 2022
Twenty years ago, Columbia scientists created a way to make neurons in a dish, a discovery that has led to clinical trials of an experimental drug that may slow the progression of ALS.
- July 13, 2022
Using EEG to identify covert consciousness in unresponsive brain-injured patients could help predict which ones may recover, find researchers at Columbia and NewYork-Presbyterian.
- May 24, 2022
A gene called FMNL2 may explain why people with hypertension, diabetes, heart disease, or obesity have a greater risk of developing Alzheimer's disease.
- May 23, 2022
A transient ischemic attack (TIA) is a stroke that usually lasts under five minutes and resolves on its own, but just because the symptoms disappear, does not mean a TIA should be ignored.